Insulet Corporation (PODD)
| Market Cap | 22.38B |
| Revenue (ttm) | 2.36B |
| Net Income (ttm) | 236.10M |
| Shares Out | 70.39M |
| EPS (ttm) | 3.32 |
| PE Ratio | 95.70 |
| Forward PE | 63.88 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 577,138 |
| Open | 323.51 |
| Previous Close | 323.58 |
| Day's Range | 317.47 - 326.29 |
| 52-Week Range | 225.37 - 353.50 |
| Beta | 1.37 |
| Analysts | Strong Buy |
| Price Target | 334.50 (+5.19%) |
| Earnings Date | Nov 6, 2025 |
About PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont... [Read more]
Financial Performance
In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for PODD stock is "Strong Buy." The 12-month stock price target is $334.5, which is an increase of 5.19% from the latest price.
News
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Pantone®, the...
Medical device maker Insulet names industry veteran Flavia Pease as CFO
Medical device maker Insulet said on Tuesday that it appointed industry veteran Flavia Pease as its new chief financial officer and expects to exceed its previously issued third-quarter total revenue ...
Insulet Announces CFO Transition
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announc...
Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript
Insulet Corporation (NASDAQ:PODD) Baird Global Healthcare Conference 2025 September 9, 2025 12:15 PM EDT Company Participants Eric Benjamin - Executive VP & COO Ana Chadwick - Executive VP & CFO Conf...
Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Insulet Corporation (NASDAQ:PODD) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 3:00 PM EDT Company Participants Ashley McEvoy - CEO, President & Director Ana Chadwick - Execut...
Insulet Elevates Eric Benjamin to Chief Operating Officer
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced t...
Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV
The Investment Committee give you their top stocks to watch for the second half.
Insulet to Participate in Upcoming Investor Conferences
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will prese...
Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold
PODD delivered strong Q2 results, exceeding revenue guidance, improving gross margin, and launching the Omnipod 5 iPhone app, strengthening its ecosystem position. Omnipod 5's pharmacy channel penetra...
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
Insulet Corporation PODD reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents.
Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Ana Maria Chadwick - Executive VP & CFO Ashley A. McEvoy - CEO, President & Director Eric Benjam...
Insulet beats second-quarter profit estimates on strong demand for insulin pumps
Medical device maker Insulet beat Wall Street estimates for second-quarter profit and revenue on strong demand for its wearable insulin pumps, sending its shares up nearly 10% in premarket trading on ...
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced f...
15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them
Growth stocks can be expensive, but if you are trying to be aggressive with a portion of your investment portfolio, you often have to pay a premium for the privilege.
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced i...
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
ACTON, Mass.--(BUSINESS WIRE)--Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association Conference.
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible wi...
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management ...
Outlier Money Flows Lift Insulet
Big Money buying shares of Insulet Corporation (PODD).
Insulet Announces Publication of 2024 Sustainability Report
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, is proud to annou...